Identification of human papillomavirus (HPV) subtype in oral cancer patients through microarray technology
European Archives of Oto-Rhino-Laryngology Dec 14, 2017
Kim SM, et al. - Researchers planned this study to ascertain the prevalence and prognosis of human papilloma virus (HPV) associated with oral squamous cell carcinoma (OSCC) according to HPV and tumor types. The obtained data indicated that the DNA microarray method could accurately detect known HPV subtypes simultaneously, however, it had limitations in detecting new subtypes. Moreover, vaccines could be used to prevent HPV-associated OSCC in patients. Thus, further studies on the prognosis and efficacy of vaccines ought to be undertaken.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries